Clinical trials for Meningioma
53 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07413796Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted SuturesMedical University of Warsaw · PI: Michał Senger, M.D.
- RECRUITINGPhase 2NCT06955169Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentRTOG Foundation, Inc. · PI: Erik P Sulman, MD,PhD
- RECRUITINGPHASE1, PHASE2NCT07150806RYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaJoshua Palmer · PI: Joshua D Palmer, MD
- RECRUITINGN/ANCT06831461Proton Versus Photon Radiotherapy in Adults With Primary Brain TumorsTata Memorial Centre
- RECRUITINGNCT07044076Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With MeningiomasCentre Hospitalier St Anne
- RECRUITINGPhase 2NCT05940493Abemaciclib in Newly Diagnosed Meningioma PatientsNader Sanai · PI: Nader Sanai, MD
- RECRUITINGNCT06874426The Impact of Endoscopic Endonasal Skull Base Surgery on OlfactionUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPhase 2NCT06326190177Lu-DOTATATE for Recurrent MeningiomaEuropean Organisation for Research and Treatment of Cancer - EORTC · PI: Prof. Nathalie Albert
- RECRUITINGPhase 2NCT06132685Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS TrialEmory University · PI: Kimberly Hoang, MD
- RECRUITINGN/ANCT06752096Robot-Assisted Neurovascular InterventionNavigantis Inc.
- RECRUITINGN/ANCT06830356Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.Centro di Riferimento Oncologico - Aviano · PI: Lorenzo Vinante
- RECRUITINGNCT06709833Meningioma and Embolism Thrombosis Risk & Investigation of CoagulationUniversity Hospital Tuebingen
- RECRUITINGN/ANCT06557512Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk MeningiomaUniversity of California, San Francisco · PI: William Chen, MD
- RECRUITINGPhase 1NCT06650163Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsJonsson Comprehensive Cancer Center · PI: Robert M Prins
- RECRUITINGPhase 2NCT06126588Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical TrialCentral Hospital, Nancy, France
- RECRUITINGPHASE1, PHASE2NCT06640582TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and MeningiomasEssen Biotech
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06668987A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent MeningiomaHeron Neutron Medical Corp.
- RECRUITINGNCT07282470Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MINDFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPhase 2NCT06275919Regorafenib for Recurrent Meningioma (MIRAGE Trial)Istituto Oncologico Veneto IRCCS · PI: Giuseppe Lombardi, MD
- RECRUITINGPhase 4NCT06377371Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATEWeill Medical College of Cornell University · PI: Jana Ivanidze, MD/PhD
- RECRUITINGEarly Phase 1NCT06632860A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive TumorsPeking Union Medical College Hospital
- RECRUITINGNCT06466720Measuring and Mapping Cognitive Decline After Brain RadiosurgeryUniversity of Nottingham · PI: Paul S Morgan, Professor of Medical Physics
- RECRUITINGPhase 2NCT06684795FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for NeurosurgeryRigshospitalet, Denmark · PI: Jane Skjøth-Rasmussen, MD, PhD
- RECRUITINGN/ANCT05895344Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III StudyCentre Francois Baclesse
- RECRUITINGN/ANCT06104930Plasma Extracellular Vesicles in Meningioma PatientsUniversity Hospital Heidelberg
- ENROLLING BY INVITATIONN/ANCT06753617Cryoablation of Brain NeoplasmErasmus Medical Center · PI: Arnaud Vincent, MD, PhD
- RECRUITINGN/ANCT06036706Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:Centre Francois Baclesse
- RECRUITINGPhase 1NCT06014905Feasibility of Acquiring Hyperpolarized Imaging in Patients With MeningiomaJavier Villaneuva-Meyer, MD · PI: Javier Villanueva-Meyer, MD
- RECRUITINGN/ANCT05727605Neurocognition After Radiotherapy in CNS- and Skull-base TumorsUniversitaire Ziekenhuizen KU Leuven · PI: Maarten Lambrecht, MD PhD
- RECRUITINGN/ANCT069552083D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological FeaturesShengjing Hospital · PI: Yu Shi, MD
- RECRUITINGN/ANCT05416567Embolization for MeningiomaSt. Olavs Hospital · PI: Ole Solheim, PhD
- RECRUITINGPhase 2NCT05023018NEO100 and High-Grade MeningiomaNeonc Technologies, Inc. · PI: Tom Chen, MD, PhD
- RECRUITINGPhase 2NCT05425004Cabozantinib for Patients With Recurrent or Progressive MeningiomaBaptist Health South Florida · PI: Rupesh Kotecha, M.D.
- RECRUITINGPHASE1, PHASE2NCT04997317Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotideUniversity Hospital, Basel, Switzerland · PI: Dominik Cordier, PD Dr. med.
- RECRUITINGNCT04638478PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRIMaastricht Radiation Oncology · PI: Karen Zegers
- RECRUITINGPhase 2NCT04659811Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent MeningiomaNancy Ann Oberheim Bush, MD · PI: Nancy Oberheim Bush, MD, PhD
- RECRUITINGN/ANCT05793034Predictive Factors for Survival in Aggressive MeningiomasFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT04427384Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)GT Medical Technologies, Inc. · PI: Michael A. Garcia, MD, MS
- RECRUITINGN/ANCT04501705Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in AdultsBeijing Sanbo Brain Hospital
- RECRUITINGPhase 2NCT04082520Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation TherapyMayo Clinic · PI: Kenneth W. Merrell, MD
- RECRUITINGN/ANCT04278118Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI StudyEmory University · PI: Bree R Eaton
- ACTIVE NOT RECRUITINGNCT04189172MiDura-Study (Neuro-Patch in Duraplasty)Aesculap AG
- RECRUITINGPhase 1NCT03631953Combination of Alpelisib and Trametinib in Progressive Refractory MeningiomasAssistance Publique Hopitaux De Marseille · PI: Jean-Oliver ARNAUD, Director
- RECRUITINGPhase 4NCT0408170168-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.Weill Medical College of Cornell University · PI: Jana Ivanidze, MD/Ph.D
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03604978Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaNational Cancer Institute (NCI) · PI: Jiayi Huang
- ACTIVE NOT RECRUITINGPhase 2NCT03971461Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk MeningiomaNYU Langone Health · PI: Erik Sulman, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03279692Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade MeningiomaMassachusetts General Hospital · PI: Priscilla Brastianos, MD
- RECRUITINGPhase 3NCT03180268Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryNRG Oncology · PI: Michael A Vogelbaum
- RECRUITINGPhase 2NCT02847559Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 MeningiomaNorthwestern University · PI: Priya Kumthekar, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02648997An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent MeningiomaDana-Farber Cancer Institute · PI: David A Reardon, MD
- ACTIVE NOT RECRUITINGN/ANCT02693990A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade MeningiomasMassachusetts General Hospital · PI: Helen A Shih, MD
- RECRUITINGPhase 2NCT02523014Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasAlliance for Clinical Trials in Oncology · PI: Priscilla Brastianos, MD
- ACTIVE NOT RECRUITINGN/ANCT01892397Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic MeningiomaMemorial Sloan Kettering Cancer Center · PI: Thomas Kaley, MD